Studies such as LEADER, SUSTAIN-6, REWIND, SELECT, and most recently the SOUL trial demonstrated that certain GLP-1 receptor agonists were associated with reductions in major adverse cardiovascular events, including heart attack, stroke, and cardiovascular death.[4][5][6][7] Much of the semaglutide cardiovascular evidence, in particular, has shaped how doctors now think about these medicines
The process was simple and I felt like the Doctor took ample time to get to know me and my symptoms
Blood Pressure GLP-1 RAs modestly reduce blood pressure, with more potent effects observed in patients with established hypertension
How Semaglutide Stabilizes Blood Sugar GLP-1 helps your pancreas release insulin when food raises your blood sugar
Diktas, Ph.D., a postdoctoral research fellow in the Ingestive Behavior, Weight Management and Health Promotion Laboratory at Pennington Biomedical Research Center, used a validated tool called the Food Noise Questionnaire (FNQ), which evaluates how often intrusive thoughts about food interfere with daily life
Additionally, bariatric surgery evaluation is suggested for patients with a BMI greater than 35, no contraindications, and who have failed more conservative weight loss measures [68]